- Reuters•7 hours ago
Large drugmakers with piles of cash are on the hunt for promising medicines being developed by small companies to treat NASH, a progressive fatty liver disease poised to become the leading cause of liver ...
- TheStreet.com•7 hours ago
The Trump administration's executive order on tax regulations could revive the defunct Allergan-Pfizer merger.
- Motley Fool•11 hours ago
Allergan, Express Scripts, and Vertex stocks look attractive in a generally overpriced market.
AGN : Summary for Allergan plc Ordinary Shares - Yahoo Finance
Allergan plc (AGN)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Day's Range||236.69 - 238.63|
|52 Week Range||184.50 - 261.27|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||6.21|
|Dividend & Yield||2.80 (1.19%)|
|1y Target Est||N/A|